Furmonertinib
- Generic Name
- Furmonertinib
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
用于既往经表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI)治疗时或治疗后出现疾病进展，并且经检测确认存在EGFR T790M突变阳性的局部晚期或转移性非小细胞性肺癌(NSCLC)成人患者的治疗。
- Associated Conditions
- -
- Associated Therapies
- -
Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities
- First Posted Date
- 2021-07-29
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 138
- Registration Number
- NCT04982900
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
🇨🇳Fujian Medical University Union Hospital, Fuzhou, Fujian, China
🇨🇳Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 64
- Registration Number
- NCT04970693
- Locations
- 🇨🇳
Sun yat-sen University Cancer Center, Guangzhou, Guangdong, China
Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT)
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2021-07-16
- Target Recruit Count
- 40
- Registration Number
- NCT04965831
Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2023-01-06
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04895930
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath